Cited by 48Pharmacological Effects and Toxicity StudiesEpilepsy research and treatmentPrenatal Substance Exposure Effects

Neurodevelopmental effects of fetal antiepileptic drug exposure

Open access
Velez-Ruiz, Naymee J., Meador, Kimford J.·2015·Drug Safety

Abstract

Many studies investigating cognitive outcomes in children of women with epilepsy report an increased risk of mental impairment. Verbal scores on neuropsychometric measures may be selectively more involved. While a variety of factors contribute to the cognitive problems of children of women with epilepsy, antiepileptic drugs (AEDs) appear to play a major role. The mechanisms by which AEDs affect neurodevelopmental outcomes remain poorly defined. Animal models suggest that AED-induced apoptosis, altered neurotransmitter environment, and impaired synaptogenesis are some of the mechanisms responsible for cognitive and behavioral teratogenesis. AEDs that are known to induce apoptosis, such as valproate, appear to affect children's neurodevelopment in a more severe fashion. Fetal valproate exposure has dose-dependent associations with reduced cognitive abilities across a range of domains, and these appear to persist at least until the age of 6. Some studies have shown neurodevelopmental deficiencies associated with the use of phenobarbital and possibly phenytoin. So far, most of the investigations available suggest that fetal exposures to lamotrigine or levetiracetam are safer with regard to cognition when compared with other AEDs. Studies on carbamazepine show contradictory results, but most information available suggests that major poor cognitive outcomes should not be attributed to this medication. Overall, children exposed to polytherapy prenatally appear to have worse cognitive and behavioral outcomes compared with children exposed to monotherapy, and with the unexposed. There is an increase risk of neurodevelopmental deficits when polytherapy involves the use of valproate versus other agents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40264-015-0269-9

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Velez-Ruiz, N. J., & Meador, K. J.
Affiliations
  • Emory University (US)
  • Stanford University (US)
Corresponding author
Meador, Kimford J.
Venue
Drug Safety
Published
2015-02-19
Volume
38
Issue
3
Pages
271-278
ISSN
  • 0114-5916 (ISSN-L)
  • 1179-1942
OpenAlex
W1988995415
Cited by
48
References
53
Citations by year
2026: 1 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 8 · 2016: 5 · 2015: 2
FWCI
1.07
Type
journal article
Language
en
Open access
Locations
  • Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Neurological Disorders and Stroke (U01NS038455, U2U01-NS038455)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
antiepileptic drugs, prenatal drug exposure, developmental neurotoxicity, cognitive impairment, valproic acid, phenobarbital, phenytoin, lamotrigine, levetiracetam, carbamazepine, polypharmacy, teratogenesis, apoptosis, synaptogenesis, neurotransmitters, dose-dependent effects
MeSH terms
Anticonvulsants, Epilepsy, Female, Humans, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Fetal Development, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review